These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6614201)

  • 1. Distributed model for drug delivery to CSF and brain tissue.
    Collins JM; Dedrick RL
    Am J Physiol; 1983 Sep; 245(3):R303-10. PubMed ID: 6614201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug entry into and distribution within brain and cerebrospinal fluid: [14C]urea pharmacokinetics.
    Rapoport SI; Fitzhugh R; Pettigrew KD; Sundaram U; Ohno K
    Am J Physiol; 1982 Mar; 242(3):R339-48. PubMed ID: 7065229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.
    Nagaya Y; Nozaki Y; Takenaka O; Watari R; Kusano K; Yoshimura T; Kusuhara H
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):57-66. PubMed ID: 26830080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNS, CSF, and extradural fluid uptake of various hydrophilic materials in the dogfish.
    Fenstermacher JD; Patlak CS
    Am J Physiol; 1977 Jan; 232(1):R45-53. PubMed ID: 835728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.
    de Lange EC; Danhof M
    Clin Pharmacokinet; 2002; 41(10):691-703. PubMed ID: 12162757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.
    Shen DD; Artru AA; Adkison KK
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1825-57. PubMed ID: 15381336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for transport in the central nervous system.
    Spector R; Spector AZ; Snodgrass SR
    Am J Physiol; 1977 Mar; 232(3):R73-9. PubMed ID: 842696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efflux of radiolabeled polyethylene glycols and albumin from rat brain.
    Cserr HF; Cooper DN; Suri PK; Patlak CS
    Am J Physiol; 1981 Apr; 240(4):F319-28. PubMed ID: 7223889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of protein binding determine rates of uptake of drugs by brain.
    Robinson PJ; Rapoport SI
    Am J Physiol; 1986 Dec; 251(6 Pt 2):R1212-20. PubMed ID: 3789202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for mathematical modelling of spatial drug distribution within the brain.
    Vendel E; Rottschäfer V; de Lange ECM
    Fluids Barriers CNS; 2019 May; 16(1):12. PubMed ID: 31092261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico prediction of brain and CSF permeation of small molecules using PLS regression models.
    Bendels S; Kansy M; Wagner B; Huwyler J
    Eur J Med Chem; 2008 Aug; 43(8):1581-92. PubMed ID: 18206268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues.
    Naseri Kouzehgarani G; Feldsien T; Engelhard HH; Mirakhur KK; Phipps C; Nimmrich V; Clausznitzer D; Lefebvre DR
    Adv Drug Deliv Rev; 2021 Jun; 173():20-59. PubMed ID: 33705875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological aspects of the penetration of drugs into the cerebrospinal fluid.
    DAVSON H; SMITH HV
    Proc R Soc Med; 1957 Nov; 50(11):963-6. PubMed ID: 13494496
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug "diffusion" within the brain.
    Fenstermacher J; Kaye T
    Ann N Y Acad Sci; 1988; 531():29-39. PubMed ID: 3382143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data.
    Gaohua L; Neuhoff S; Johnson TN; Rostami-Hodjegan A; Jamei M
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):224-33. PubMed ID: 27236639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF as a surrogate for assessing CNS exposure: an industrial perspective.
    Lin JH
    Curr Drug Metab; 2008 Jan; 9(1):46-59. PubMed ID: 18220571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans.
    Spector R; Robert Snodgrass S; Johanson CE
    Exp Neurol; 2015 Nov; 273():57-68. PubMed ID: 26247808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.
    Stain-Texier F; Boschi G; Sandouk P; Scherrmann JM
    Br J Pharmacol; 1999 Oct; 128(4):917-24. PubMed ID: 10556926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune surveillance of central nervous system bypasses blood-brain barrier and blood-cerebrospinal-fluid barrier: revealed with the New Marburg cerebrospinal-fluid model in healthy humans.
    Kleine TO
    Cytometry A; 2015 Mar; 87(3):227-43. PubMed ID: 25641944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.